Lupus Research Alliance Honors Carola Vinuesa, MD, PhD, for Discovering a Specific Gene Variant that Causes Lupus in Some Patients
Retrieved on:
Thursday, June 22, 2023
Francis Crick Institute, Mouse, TLR7, Lupus Research Alliance, Weill Cornell Medicine, Guanosine, Toll-like receptor 7, Prevalence, Genetics, Federation of Clinical Immunology Societies, Attention deficit hyperactivity disorder predominantly inattentive, Australian Academy of Science, Medical Research Council, Mutation, Cas9, Research, SLE, Gottschalk Medal, Lupus, RNA, National Health and Medical Research Council, Doctor of Philosophy, Government, Autoimmunity, Assistant, FAA, The Prize, X chromosome, National Health, Patient, FRS, Immune system, Diagnosis, Bacteria, Royal Society, NHMRC, Genome, Autoantibody, Disease, Pharmaceutical industry, Vaccine, Science, MD
The Lupus Research Alliance awarded its 2023 Lupus Insight Prize to Carola Vinuesa, MD, PhD, of The Francis Crick Institute.
Key Points:
- The Lupus Research Alliance awarded its 2023 Lupus Insight Prize to Carola Vinuesa, MD, PhD, of The Francis Crick Institute.
- Many lupus patients display increased TLR7 activity; however, disease-causing mutations in the TLR7 gene had not been identified.
- "I am honored to receive this most prestigious award from the Lupus Research Alliance in recognition of our discovery of a genetic cause of lupus.
- To determine whether the TLR7 mutation identified causes lupus, Dr. Vinuesa's team used a gene-editing tool, CRISPR/Cas9, to introduce the specific variant into mice.